Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Predictors for vertebral height deterioration in fractured vertebrae operated by percutaneous vertebroplasty

Abstract

Background

Vertebral height loss of fractured vertebrae treated by percutaneous vertebral augmentation (PVA) for osteoporotic vertebral compression fracture (OVCFs) during follow-up had been reported. Mostly, vertebral height loss and its relevant terms (e.g., “recompression”, “recollapse” and “refracture”) were defined according to immediate postoperative vertebral height as the baseline in published studies. By contrast, vertebral height deterioration (VHD) was defined according to preoperative vertebral height as the baseline in the present study. The aim of the study was to reveal predictors for VHD in fractured vertebrae operated by percutaneous vertebroplasty (PVP), with a specific focus on surgical factors.

Methods

All patients with OVCFs treated by PVP between April 2016 and September 2018 were retrospectively reviewed. Patients were followed up for at least 12 months after procedure according to treatment protocol. VHD was defined as the presence of a decrease of vertebral height at final follow-up compared to preoperative. Clinical, radiological and surgical factors that might affect occurrence of VHD were assessed using univariate and multivariate analyses.

Results

A total of 543 patients (females 80%, age 73.2 ± 8.1 years) with 681 fractured vertebrae who underwent PVP were enrolled. Mean follow-up time was 28.9 ± 13.4 months (range, 12–59 months). Incidence of VHD in fractured vertebrae was 48.9% (333/681). One clinical factor and four radiological factors, including fracture age (OR = 0.513, 95% CI 0.385–0.683, p = 0.000), fracture location (OR = 2.878, 95% CI 1.994–4.152, p = 0.000), fracture severity (OR = 0.521, 95% CI 0.386–0.703, p = 0.000), cortical defect on lateral wall (OR = 2.535, 95% CI 1.351–4.758, p = 0.004) and intravertebral cleft (OR = 2.362, 95% CI 1.488–3.750, p = 0.000), were independent predictors for VHD. However, all the surgical factors evaluated were not significant in final model analysis.

Conclusions

Surgical factors might play a negligible effect on VHD. VHD might be due to natural course of fracture/osteoporosis.

Peer Review reports

Background

Percutaneous vertebral augmentation (PVA), including percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty (PKP), had been widely accepted as safe and effective treatment option for osteoporotic vertebral compression fracture (OVCFs). For the augmented vertebrae, vertebral height had been paid attention preoperatively, postoperatively and at follow-up [1, 2]. Vertebral height restoration was defined as the differences between postoperative and preoperative. It was a parameter usually indicating the immediate effect of procedure [3]. Vertebral height loss was defined as the changes between at follow-up and immediate postoperative. It was a parameter tentatively reporting the gradual consequences of disease [4, 5]. Based on this meaning of vertebral height loss, some relevant terms in literature, such as “recompression”, “recollapse” or “refracture”, were further defined qualitatively and quantitatively [4,5,6,7,8].

Potential mechanisms underlying vertebral height loss might attribute to the progression of osteoporosis, bone remodeling processes or biomechanical factors (e.g., bending load or static stress). Clinically, in order to provide a better understanding on whether vertebral height loss was procedure-related or part of the natural features of patient/fracture, multivariate analysis [4,5,6,7,8,9] and pooled analysis [10, 11] had been used to identify risk factors for the occurrence of vertebral height loss. Many procedural factors, such as morphology of cement distribution (solid mass) [6, 7, 10], region of cement distribution (non-cement-endplate-contact) [5, 8], lower volume of cement injected [9, 11] and higher vertebral height restoration [4,5,6,7,8, 10, 11], were found to be significantly associated with vertebral height loss. These results might have been thought to be meaningful to guide management in surgical practice. Also, significant patient-related and radiological factors were discussed.

However, most investigates had token immediate postoperative vertebral height as a baseline to define vertebral height loss in their studies [1, 4,5,6,7,8,9, 12, 13]. Immediate postoperative was a time point when fracture was unhealed or unstable. Theoretically, the value of immediate postoperative vertebral height was the peak point due to a compensatory height increase of unstable property of fracture [6], as vertebral height increase or decrease could partially contribute to the effect of postual reduction or standing up. Hence, vertebral height loss would have been overestimated on both the occurrence and the degree. Subsequently, significant risk factors of vertebral height loss in literature would have been misleading.

In order to cancel out the bias, we defined vertebral height deterioration (VHD) as the presence of a decrease of vertebral height at follow-up compared to preoperative. The definition of VHD was inherently different from that of vertebral height loss, as their baselines were fundamentally different. This might help to provide further insight into whether or not vertebroplasty can avoid further collapse of cemented vertebrae. The aim of the study was to reveal predictors for VHD in fractured vertebrae operated by PVP, with a specific focus on surgical factors.

Methods

Patient population

All patients with OVCFs treated by PVP between April 2016 and September 2018 were retrospectively reviewed. A total of 742 patients were screened during the study period. The study protocol was approved by our institutional review board. The diagnosis of osteoporosis was made by a T-score < -2.5 of bone mineral density (BMD) according to dural-enegry X-ray absorptiometry (DEXA), or by radiographic features [definitive decreased bone density on plain radiographs or computed tomography (CT)], or by clinical findings (fracture due to a minor or no trauma). The diagnosis of vertebral fracture was made by plain radiographs, CT or magnetic resonance imaging (MRI). The inclusion criteria included: (1) one or more OVCFs, (2) 5 or more scores of visual analogue scale (VAS) of focal back pain, (3) level of fracture of T6 or lower, (4) aged 60 years or more, (5) at least 12 months of follow-up. The exclusion criteria included: (1) patients who had previous PVA or other spinal surgery (n = 98), (2) incomplete radiologic data (n = 86), (3) unilateral vertebroplasty (n = 10), (4) malignant vertebral fracture (n = 5).

Surgical procedure and follow-up

All the cases were performed by one of three senior surgeons. Under local anesthesia, a routine transpedicular approach was used bilaterally to perform PVP. Then, polymethylmethacrylate (PMMA) was carefully injected into the fractured vertebra with the fluoroscopic control. The injection was terminated when intraoperative live fluoroscopy images demonstrated progressive symmetrical satisfactory filling of the vertebral body, or when cement leakage was noted. Patients with multiple level fractures were treated using a one-stage procedure.

Radiographs were obtained preoperatively, postoperatively and at follow-up (3, 12 months after procedure, and subsequently per year). Also, a CT scan was completed to identity cement leakage postoperatively.

Clinical, radiological and surgical evaluation

Clinical data were gathered retrospectively from case notes by one author (Y. D. L.). Clinical data included sex, age, body mass index (BMI), fracture cause, fracture levels, fracture age, follow-up time. Fracture age was classified according to duration of symptom as either acute (< 2 weeks), subacute (2–6 weeks), or chronic (>6 weeks) [14].

Radiological data included fracture location, fracture type, fracture severity, fracture region, cortical disruption, intravertebral cleft, spinal canal compromise, and basivertebral foramen. Fracture type was assessed on lateral radiographs and classified according to Genant et al. as either wedge, biconcave, or crush [15]. According to a method of semiquantitative grading of vertebral fractures, fracture severity was classified according to degree of vertebral body reduction in any (anterior, middle, or posterior) height as mild (20–25%), moderate (26–40%), and severe (>40%) on lateral radiographs [15]. Fracture region was detected by MRI and classified according to a modification of Kanchiku methods into three types: inferior, superior, total [16]. Cortical disruption was defined as evident discontinuation at endplates, or anterior, posterior, lateral wall of vertebral body on MRI or CT [17]. An intravertebral cleft was defined as an intravertebral, abnormal, well-demarcated, linear or cystic hypointensity similar to air on radiography or T1-weighted MRI sequences; an abnormal, well-demarcated, linear or cystic hyperintensity similar to cerebrospinal fluid on STIR sequences [18]. Spinal canal compromise was indicated abnormality of spinal canal area due to intrusion of posterior wall on axial CT [19]. Basivertebral foramen was assessed as presence of triangle or trapezoid shaped foramen at posterior wall on middle-sagittal CT or MRI, or as presence of hemicycle shaped foramen on axial CT [20].

Surgical data included morphology of cement, region of cement, cement leakage, cement volume, vertebral angle restoration, and vertebral height restoration. Morphology of cement was assessed on lateral radiographs and classified according to Han et al. into two types: interdigitation, when cement was interspersed throughout trabeculae, and solid mass, when cement was lumped without interspersion [21]. Inferior-to-superior region of cement was assessed on lateral radiographs and classified according to a modification of Kim methods into three types: no-endplate contact, one-endplate contact, and two-endplate contact [1]. Lateral-to-lateral region was assessed on frontal radiographs and classified according to He et al. into two types: H-type, when cement was bilaterally discontinuous or partly interdigitated, O-type, when cement was bilaterally continuous and completely interdigitated [22]. Anterior-to-posterior region was assessed on lateral radiographs and classified according to ratio of cement/vertebra anteroposterior dimension as either ≥ 2/3, or<2/3. Any cement leakage was assessed on postoperative CT and classified into 4 types: through basivertebral vein (type B), through segmental vein (type S), through cortical defect (type-C), and intradiscal leakage (type D) [23, 24]. Vertebral angle restoration was calculated as the difference between immediate postoperative and preoperative vertebral angle. Of note, vertebral angle was defined as the angle by two lines passing along fractured vertebra’s endplates [25]. Vertebral height restoration was calculated as the difference between immediate postoperative and preoperative vertebral height. Of note, vertebral height was measured according to Kim et al. at each anterior, middle, and posterior thirds, and then the smallest site one was divided by a mean value of the corresponding cortical heights of the 2 nearest nonfractured vertebrae (Fig. 1) [2].

Fig. 1
figure 1

The absolute value of vertebral height is measured at each anterior (a), middle (b), and posterior (c) thirds for one fractured vertebra and two nearest nonfractured vertebrae. For this fractured vertebra, a0 was the smallest among the three value (a0, b0 and c0). Hence, its vertebral height = a0/[(a1 + a2)/2]

Radiological and surgical data were collected retrospectively from radiographs, CT and MRI, and evaluated independently by two authors (B. Q. T. and L. B. C.), with discrepancies resolved by a third author (X. M. C.).

Definition of vertebral height deterioration (VHD)

VHD was defined as the presence of a decrease of vertebral height at follow-up compared to preoperative (Fig. 2). On the contrary, vertebral height well-maintained (VHW) was defined as the absence of a decrease or the presence of an increase of vertebral height at follow-up compared to preoperative.

Fig. 2
figure 2

Vertebral height deterioration (VHD) in T12 was observed, as a decrease in vertebral height at final follow-up (C) compared to preoperative (A). A Preoperative lateral radiograph. Preoperative vertebral height = a0/[(a1 + a2)/2] = 0.79. B Lateral radiograph at 1-day postoperative time point. Postoperative vertebral height = a0/[(a1 + a2)/2] = 0.95. C Lateral radiograph at final follow-up (26-month postoperative time point). Final follow-up vertebral height = a0/[(a1 + a2)/2] = 0.61. In this case, vertebral height deterioration rate (VHDR) = (preoperative vertebral height– final follow-up vertebral height) / preoperative vertebral height × 100% = (0.79–0.61) / 0.79 × 100% = 22.3%

Of note, VHD rate (VHDR) was calculated as: (preoperative vertebral height– final follow-up vertebral height) / preoperative vertebral height × 100% (Fig. 2).

Statistical analysis

Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS), V 19.0 (Chicago, IL, USA). Univariate logistic regression models were used to explore effects of clinical, radiological and surgical parameters against occurrence of VHD. Significant correlates at P values of less than 0.05 were retained for final multivariate model. Multivariate binary logistic regression model was performed using a stepwise approach to identify independent predictors for VHD. The statistical significance of potential predictors was assessed with the likelihood ratio test. In the final model, a P value less than 0.05 was considered significant.

Results

A total of 543 patients with 681 vertebrae were finally included. Study population was made up of 108 males and 435 females with a mean age of 73.2 ± 8.1 years (range, 60–95 years) (Table 1). Mean follow-up time was 28.9 ± 13.4 months (range, 12–59 months). Clinical, radiological and surgical features were documented (Tables 1, 2 and 3).

Table 1 Clinical features
Table 2 Radiological features

VHD and VHW were found in 48.9% (333/681) and 51.1% (348/681) of all treated vertebrae, respectively. Incidence of VHDR 1–20%, 21–40%, 41–60%, ≥ 61% were 25.3% (172/681), 17.9% (122/681), 4.8% (33/681), 0.9% (6/681), respectively (Fig. 3).

Fig. 3
figure 3

Percentage of vertebrae (N = 681) in each group. VHW, vertebral height well-maintained. VHDR, vertebral height deterioration rate

Univariate analysis showed that nine significant factors related to VHD were fracture age, fracture location, fracture severity, cortical disruption on anterior wall, cortical disruption on lateral wall, intravertebral cleft, spinal canal compromise, morphology of cement, and type-C leakage (p<0.05). Of note, with regard to surgical factors, region of cement, cement volume, wedge angle restoration, and vertebral height restoration did not reach significance in univariate analysis (Table 4).

Table 3 Surgical features

Multivariate analysis was performed to determine risk factors for VHD as well as their effects. Fracture location, cortical disruption on lateral wall and intravertebral cleft were three risk factors. Thoracolumbar locations exhibited 2.9-fold more at risk for VHD than non-thoracolumbar locations. Cortical disruption on lateral wall and intravertebral cleft exhibited 2.5-fold, 2.4-fold more at risk for VHD, respectively. In contrast, fracture severity and fracture age were two protective factors. For every increase of per grade of fracture severity and fracture age, risk of VHD decreased by 52.1%, 51.3%, respectively. Of note, morphology of cement (OR, 1.476; 95% CI, 0.952–2.287; p = 0.082) did not demonstrate its effectiveness to predict VHD in multivariate analysis. Cortical disruption on anterior wall (OR, 1.056; 95% CI, 0.649–1.719; p = 0.827), spinal canal compromise (OR, 1.066; 95% CI, 0.716–1.588; p = 0.753), type-C leakage (OR, 2.126; 95% CI, 0.979–4.619; p = 0.057) did not reach significance in final model either (Table 5).

Table 4 Results of univariate analysis for vertebral height deterioration (VHD) in fractured vertebrae
Table 5 Results of multivariate analysis for vertebral height deterioration (VHD) in fractured vertebrae

Discussion

To our knowledge, qualitatively there were consistent definitions of vertebral height loss, as all the baselines were based on the value of immediate postoperative vertebral height. However, quantitatively the diagnosing criteria of vertebral height loss varied from absolute value of anterior vertebral height decrease ≥ 1 mm [4], absolute value of middle vertebral height decrease ≥ 2 mm [5], absolute value of at least one (anterior, meddle or posterior) vertebral vertebral height decrease ≥ 4 mm [12], absolute value of whole vertebral vertebral height decrease ≥ 4 mm [6], ≥ 15% progression of vertebral compression rate [7, 8], to ≥ 10° progression of local kyphotic angle [7]. In previous PVA series, incidence of vertebral height loss varied from 14.0 to 63.3% [4,5,6,7,8, 12]. In our present study, VHD was defined according to preoperative vertebral height as a baseline. Incidence of VHD in fractured vertebrae operated by PVP was 48.9% (333/681). Of note, only 0.6% (4/681) needed a repeated PVP. Mean follow-up time in present study were comparable to that of previous studies [1, 2, 4,5,6,7,8,9] and sufficient to capture VHD.

Noticeably, the critical differences on results between our study and previous studies were that with regard to surgical factors there were negative results in our study but positive results in any one of previous studies. It might imply that potential magnitude of overestimation according to previous definition did exist. Hence, this was one of reasons why we specifically focused on surgical factors.

It had been accepted that the reason for vertebral height loss after PVA was multifactorial. Some of clinical or radiological factors were significantly associated with vertebral height loss in previous studies [1, 4,5,6,7,8,9,10,11,12,13]. Similarly, in the present study, one clinical and four radiological factors were independent predictors for VHD.

Fracture age was one clinical factor that was significantly associated with VHD. The result was inconsistent with that of many previous studies [1, 5, 6]. One possible explanation was that variation existed between series. For example, predominance of fracture age differed in study population [1, 5, 6].

With respect to radiological parameters, thoracolumbar location was identified to be the strongest risk factor for VHD in the present study. In most multivariate analysis [4,5,6,7,8], thoracolumbar location was not risk factor for vertebral height loss, but it did demonstrate significance in pooled analysis [10]. It makes intuitive sense, as it is the most mobile region where fractures are predisposed to instability or union, it fundamentally increases risk of gradual VHD. Cortical disruption on lateral wall was a second radiological predictor for VHD. Considering that there were negative results on anterior wall, posterior wall and endplates, it might be presumed that an intact lateral wall may pay a key role in maintaining vertebral height for OVCFs patients. Intravertebral cleft was a third radiological predictor for VHD. The results was in line with that of most series [1, 5, 7, 8, 13] and pooled analysis [10, 11]. Plausible explanation may stem from the biomechanical feature of augmented vertebra, given that intravertebral cleft was vulnerable to form unfavorable morphology and insufficient region of cement [1, 5, 7, 8, 10, 11, 13]. Whereas, we speculated that hidden reason may be attributable to pathogenesis of intravertebral cleft itself, as it indicated histological osteonerosis due to avascularity [26, 27]. Given that procedure could not reverse this pathophysiological progress, gradual VHD might not be ceased. Our speculation was similar to that of Heo et al. [13]. Moreover, fracture severity was the fourth radiological factor significantly associated with VHD. The result was not in agreement with that of most series [1, 6, 7, 13]. This was presumed that heterogeneity existed in methodologies. For example, fracture severity had been evaluated by categorical variable as two grades (mild vs. others) [7], or by continuous variable as percentage or ratio [1, 6, 13].

Conversely, with respect to surgical parameters, none was an independent predictor for VDH in our final analysis. It was noted that, in the light of previous literature, one or more surgical parameters had been identified to be significantly associated with vertebral height loss in each study [1, 4,5,6,7,8,9,10,11,12,13]. Hence, several factors must be discussed. First, biomechanically, cancellous bone surrounding cement bolus was acted as the weakest link in the chain of force transmission [28]. As solid mass had been regarded as a more pathological distribution way occupying the space [10, 29], it was more likely to crush progressively under repetitive loading conditions [28]. Clinically, solid mass was found to be an independent risk factor for vertebral height loss [6, 7, 10]. Second, biomechanically, two-endplate contact was demonstrated to definitely reduce stress transfer and provide sufficient strengthening in finite element study [30]. Clinically, no-endplate contact was proved to be an independent predictor for vertebral height loss [1, 5, 8]. Third, higher vertebral height restoration and lower volume of cement were reported to be another two significant risk factors for vertebral height loss [4,5,6,7,8,9,10,11, 13]. According to these previous results, surgeons might have attempted to acquire interdigitation of cement in morphology [6, 7, 10], obtain two-endplate contact of cement in region [5, 8], avoid a greater vertebral height restoration [4,5,6,7,8, 10, 11, 13] and inject a higher volume of cement [9, 11], when seeking to reduce the risk of vertebral height loss.

However, all these surgical factors did not reach significance in our final model analysis. One explanation was that confounding factors existed. For example, solid mass was significantly associated with intravertebral cleft [7, 8, 12, 13]. More importantly, the causality would be that using the definition of VHD in analysis had canceled out the bias on vertebral height change, as the change was partially attributable to cement volumetric effect as well as postural reduction during procedure. Parsimonious model selection probably did not exclude important factors in final analysis. In addition, a total of 681 vertebrae were enrolled and 31 parameters were evaluated, making it sufficiently large and comprehensive to allow statistically valid conclusions to be drawn. To some degree, results in our study implied that surgeon’s manipulating surgical factors to avoid the occurrence of VHD might not matter.

Whereas, results should be cautiously explained under certain circumstances. For example, mean volume of cement injected was 5.2 ± 1.8 ml, or follow-up time was at least 12 months in this series. Still, it should be emphasized that surgical parameters were crucial for each case in practice, as they were closely related to clinical and radiological outcomes. Of note, vertebroplasty had showed better results on vertebral height at long-term follow-up compared to conservative treatment in previous study [25].

Our study adds valuable new information to the literature and could guide high quality future studies on this issue. The definition of VHD was proposed in analysis, providing a better understanding of its incidence and risk factors. At least, we suggested that surgeons should not overestimate the long-term effect on vertebral height maintenance from vertebroplasty.

Several limitations must also be acknowledged. First and foremost, there was inherent limitation of retrospective design, such as potential selection bias and data completeness issues. Hence, our results should not be overstated beyond the methodology of this study. Second, classification of fracture age may be primitive, as it was difficult to record accurate duration of symptoms in aged patients who had memory impairment. Third, many severe fractures were excluded, as they were usually considered as candidates for PKP or spinal reconstructive surgery at our center. Third, we did not include kyphotic angle restoration [6,7,8, 11] in analysis. Kyphotic angle was more primitive than vertebral angle, as the former contains one additional vertical disc and normal vertebra, which biased effect of procedure. Fourth, comorbidities, T-score of BMD / severity of osteoporosis, and medication for osteoporosis were not evaluated, which might bias the results. Fifth, we could not evaluate the relationship between VHD and pain relief, as this was beyond the landscape of current study. Sixth, the study was conducted at a single center in China, and the results may not be applicable to other populations with different demographics. Seventh, there was lack of a control group for conservative treatment or internal fixation. The clinical meaning of VHD needs to explore in further studies.

Conclusions

VHD in fractured vertebrae operated by PVP might be inevitable, as it was prevalent (48.9%, 333/681). One clinical factor and four radiological factors, including fracture age, fracture location, cortical defect on lateral wall, intravertebral cleft and fracture severity, were significant predictors for VHD. However, none of surgical factors reached significance in final analysis. The results implied that surgical factors might play a negligible effect on HVD. VHD might be due to natural course of fracture/osteoporosis.

Data availability

The datasets used and analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

PVA:

Percutaneous vertebral augmentation

OVCFs:

Osteoporotic vertebral compression fractures

VHD:

Vertebral height deterioration

PVP:

Percutaneous vertebroplasty

PKP:

Percutaneous kyphoplasty

BMD:

Bone mineral density

DEXA:

Dural-enegry X-ray absorptiometry

CT:

Computed tomography

MRI:

Magnetic resonance imaging

VAS:

Visual analogue scale

PMMA:

Polymethylmethacrylate

BMI:

Body mass index

VHDR:

Vertebral height deterioration rate

SPSS:

Statistical package for the social sciences

References

  1. Kim Y, Rhyu K. Recompression of vertebral body after balloon kyphoplasty for osteoporotic vertebral compression fracture. Eur Spine J. 2010;19:1907–12.

    PubMed  PubMed Central  Google Scholar 

  2. Kim SI, Ha KY, Cho YS, et al. Delayed height loss after kyphoplasty in osteoporotic vertebral fracture with severe collapse: comparison with vertebroplasty. World Neurosurg. 2018;119:e580–8.

    PubMed  Google Scholar 

  3. Teng MM, Wei CJ, Wei LC, et al. Kyphosis correction and height restoration effects of percutaneous vertebroplasty. AJNR Am J Neuroradiol. 2003;24(9):1893–900.

    PubMed  PubMed Central  Google Scholar 

  4. Lin WC, Lee YC, Lee CH, et al. Refractures in cemented vertebrae after percutaneous vertebroplasty: a retrospective analysis. Eur Spine J. 2008;17(4):592–9.

    PubMed  PubMed Central  Google Scholar 

  5. Wang C, Zhang X, Liu J, et al. Percutaneous kyphoplasty: risk factors for recollapse of cemented vertebrae. World Neurosurg. 2019;130:e307–15.

    PubMed  Google Scholar 

  6. Niu J, Zhou H, Meng Q, et al. Factors affecting recompression of augmented vertebrae after successful percutaneous balloon kyphoplasty: a retrospective analysis. Acta Radiol. 2015;56(11):1380–7.

    PubMed  Google Scholar 

  7. Yu WB, Jiang XB, Liang D, et al. Risk factors and score for recollapse of the augmented vertebrae after percutaneous vertebroplasty in osteoporotic vertebral compression fractures. Osteoporos Int. 2019;30(2):423–30.

    PubMed  CAS  Google Scholar 

  8. Xiong YC, Guo W, Xu F, et al. Refracture of the cemented vertebrae after percutaneous vertebroplasty: risk factors and imaging findings. BMC Musculoskelet Disord. 2021;22(1):459.

    PubMed  PubMed Central  Google Scholar 

  9. Li YX, Guo DQ, Zhang SC, et al. Risk factor analysis for re-collapse of cemented vertebrae after percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP). Int Orthop. 2018;42(9):2131–9.

    PubMed  Google Scholar 

  10. Yu W, Xu W, Jiang X, et al. Risk factors for recollapse of the augmented vertebrae after percutaneous vertebral augmentation: a systematic review and meta-analysis. World Neurosurg. 2018;111:119–29.

    PubMed  Google Scholar 

  11. Zhu S, Su Q, Zhang Y, et al. Risk factors of cemented vertebral refracture after percutaneous vertebral augmentation: a systematic review and meta-analysis. Neuroradiology. 2020;62(11):1353–60.

    PubMed  Google Scholar 

  12. He D, Lou C, Yu W, et al. Cement distribution patterns are associated with recompression in cemented vertebrae after percutaneous vertebroplasty: a retrospective study. World Neurosurg. 2018;120:e1–7.

    PubMed  Google Scholar 

  13. Heo DH, Chin DK, Yoon YS, et al. Recollapse of previous vertebral compression fracture after percutaneous vertebroplasty. Osteoporos Int. 2009;20(3):473–80.

    PubMed  CAS  Google Scholar 

  14. Nieuwenhuijse MJ, van Erkel AR, Dijkstra PD. Percutaneous vertebroplasty for subacute and chronic painful osteoporotic vertebral compression fractures can safely be undertaken in the first year after the onset of symptoms. J Bone Joint Surg Br. 2012;94(6):815–20.

    PubMed  CAS  Google Scholar 

  15. Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique. J Bone Min Res. 1993;8:1137–48.

    CAS  Google Scholar 

  16. Kanchiku T, Taguchi T, Kawai S. Magnetic resonance imaging diagnosis and new classification of the osteoporotic vertebral fracture. J Orthop Sci. 2003;8(4):463–6.

    PubMed  Google Scholar 

  17. Koh YH, Han D, Cha JH, et al. Vertebroplasty: magnetic resonance findings related to cement leakage risk. Acta Radiol. 2007;48:315–20.

    PubMed  CAS  Google Scholar 

  18. Nieuwenhuijse MJ, van Rijswijk CS, van Erkel AR, et al. The intravertebral cleft in painful long-standing osteoporotic vertebral compression fractures treated with percutaneous vertebroplasty diagnostic assessment and clinical significance. Spine (Phila Pa 1976). 2012;37(11):974–81.

    PubMed  Google Scholar 

  19. Mumford J, Weinstein JN, Spratt KF, et al. Thoracolumbar burst fractures: the clinical efficacy and outcome of nonoperative management. Spine (Phila Pa 1976). 1993;18(8):955–70.

    PubMed  CAS  Google Scholar 

  20. Wang C, Fan S, Liu J, et al. Basivertebral foramen could be connected with intravertebral cleft: a potential risk factors of cement leakage in percutaneous kyphoplasty. Spine J. 2014;14(8):1551–8.

    PubMed  Google Scholar 

  21. Han I, Chin D, Kun S, et al. Magnetic resonance imaging findings of subsequent fractures after vertebroplasty. Neurosurgery. 2009;64:740–4.

    PubMed  Google Scholar 

  22. He S, Zhang Y, Lv N, et al. The effect of bone cement distribution on clinical efficacy after percutaneous kyphoplasty for osteoporotic vertebral compression fractures. Medicine. 2019;98(50):e18217.

    PubMed  PubMed Central  Google Scholar 

  23. Yeom JS, Kim WJ, Choy WS, et al. Leakage of cement in percutaneous transpedicular vertebroplasty for painful osteoporotic compression fractures. J Bone Joint Surg Br. 2003;85(1):83–9.

    PubMed  CAS  Google Scholar 

  24. Tomé-Bermejo F, Piñera AR, Duran-Álvarez C, et al. Identification of risk factors for the occurrence of cement leakage during percutaneous vertebroplasty for painful osteoporotic or malignant vertebral fracture. Spine (Phila Pa 1976). 2014;39(11):E693–700.

    PubMed  Google Scholar 

  25. Martikos K, Greggi T, Faldini C, et al. Osteoporotic thoracolumbar compression fractures: long-term retrospective comparison between vertebroplasty and Conservative treatment. Eur Spine J. 2018;27(Suppl 2):244–7.

    PubMed  Google Scholar 

  26. Libicher M, Appelt A, Berger I, et al. The intravertebral vacuum phenomen as specific sign of osteonecrosis in vertebral compression fractures: results from a radiological and histological study. Eur Radiol. 2007;17:2248–52.

    PubMed  Google Scholar 

  27. Kim YC, Kim YH, Ha KY. Pathomechnism of intravertebal clefts in osteoporotic compression fractures of the spine. Spine J. 2014;14(4):659–66.

    PubMed  Google Scholar 

  28. Kim MJ, Lindsey DP, Hannibal M, et al. Vertebroplasty versus kyphoplasty: Biomechanical behavior under repetitive loading conditions. Spine (Phila Pa 1976). 2006;31(18):2079–84.

    PubMed  Google Scholar 

  29. Yang DH, Cho KH, Chung YS, et al. Effect of vertebroplasty with bone filler device and comparison with balloon kyphoplasty. Eur Spine J. 2014;23(12):2718–25.

    PubMed  Google Scholar 

  30. Chevalier Y, Pahr D, Charlebois M, et al. Cement distribution, volume, and compliance in vertebroplasty: some answers from an anatomy-based nonlinear finite element study. Spine (Phila Pa 1976). 2008;33(16):1722–30.

    PubMed  Google Scholar 

Download references

Acknowledgements

We thank Han Wen (Peking University, Medical College) for his assistance in statistical analysis.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

BQ T and L L designed this study. BQ T and XM C analyzed the raw materials and drafted the manuscript. L L revised the manuscript to its final revision. LB C YH W, X Y and YD L provided helpful advice on the manuscript. BQ T, XM C, LB C, YH W, X Y and YD L performed the surgery. BQ T, XM C, LB C and YD L participated in data collection. All authors were involved in writing the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Liang Liu.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the institutional review boards/Ethics Committees of Beijing Luhe Hospital (2024-LHYY-108-02), and was conducted in compliance with the ethical principles of the Helsinki Declaration of 1975. Because this was a retrospective study, oral informed consent was obtained from the patients or their family members.

Consent for publication

Not Applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, B., Chen, X., Cui, L. et al. Predictors for vertebral height deterioration in fractured vertebrae operated by percutaneous vertebroplasty. BMC Musculoskelet Disord 26, 327 (2025). https://doi.org/10.1186/s12891-025-08574-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-025-08574-3

Keywords